Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial.
Study Goal
The researchers aimed to assess the effects of the DASH diet, which includes low-fat dairy, on lipid profiles and oxidative stress biomarkers in overweight and obese women with PCOS.
Results Summary
The DASH diet, rich in low-fat dairy, significantly improved weight, BMI, triglycerides, VLDL cholesterol, and oxidative stress markers (TAC and GSH) compared to the control diet.
Population
Overweight and obese women diagnosed with polycystic ovary syndrome (PCOS).
Effective Dosage
Not specified (diet composition: 52% carbohydrates, 18% proteins, 30% total fats, with DASH emphasizing fruits, vegetables, whole grains, and low-fat dairy).
Duration
8 weeks
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
DASH diet | decrease | weight | overweight and obese women with polycystic ovary syndrome (PCOS) | -4.4 versus -1.5 kg | resulted in a significant decrease | #1 |
DASH diet | decrease | body mass index | overweight and obese women with polycystic ovary syndrome (PCOS) | -1.7 versus -0.6 kg/m(2) | resulted in a significant decrease | #2 |
DASH diet | decrease | serum triglycerides | overweight and obese women with polycystic ovary syndrome (PCOS) | -10.0 versus +19.2 mg/dL | decreased | #3 |
DASH diet | decrease | very-low-density lipoprotein cholesterol levels | overweight and obese women with polycystic ovary syndrome (PCOS) | -2.0 versus +3.9 mg/dL | decreased | #4 |
DASH diet | increase | plasma total antioxidant capacity (TAC) | overweight and obese women with polycystic ovary syndrome (PCOS) | +98.6 versus -174.8 mmol/L | Increased concentrations | #5 |
DASH diet | increase | total glutathione (GSH) | overweight and obese women with polycystic ovary syndrome (PCOS) | +66.4 versus -155.6 μmol/L | Increased concentrations | #6 |
DASH diet | decrease | serum insulin | overweight and obese women with polycystic ovary syndrome (PCOS) | - | led to a significant reduction | #7 |
DASH diet | decrease | triglycerides | overweight and obese women with polycystic ovary syndrome (PCOS) | - | led to a significant reduction | #8 |
DASH diet | decrease | very-low-density lipoprotein cholesterol | overweight and obese women with polycystic ovary syndrome (PCOS) | - | led to a significant reduction | #9 |
DASH diet | increase | TAC | overweight and obese women with polycystic ovary syndrome (PCOS) | - | led to a significant increase | #10 |
DASH diet | increase | GSH levels | overweight and obese women with polycystic ovary syndrome (PCOS) | - | led to a significant increase | #11 |
OBJECTIVE: The aim of this study was to assess the effects of the Dietary Approaches to Stop Hypertension (DASH) diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome (PCOS). METHODS: This randomized controlled clinical trial was conducted with 48 women diagnosed with PCOS. The women were randomly assigned to consume either the control (n = 24) or DASH diet (n = 24) for 8 wk. Both diets were designed to be calorie-restricted. Both diets consisted of 52% carbohydrates, 18% proteins, and 30% total fats. The DASH diet was designed to be rich in fruits, vegetables, whole grains, and low-fat dairy products and to be low in saturated fats, cholesterol, and refined grains. Fasting blood samples were taken at baseline and after 8-wk intervention to measure lipid profiles and biomarkers of oxidative stress including plasma total antioxidant capacity (TAC) and total glutathione (GSH). RESULTS: Adherence to the DASH diet, compared with the control diet, resulted in a significant decrease in weight (-4.4 versus -1.5 kg; P < 0.001) and body mass index (-1.7 versus -0.6 kg/m(2); P < 0.001), decreased serum triglycerides (-10.0 versus +19.2 mg/dL; P interaction = 0.005) and very-low-density lipoprotein cholesterol levels (-2.0 versus +3.9 mg/dL; P interaction = 0.005). Increased concentrations of TAC (+98.6 versus -174.8 mmol/L; P interaction <0.001) and GSH (+66.4 versus -155.6 μmol/L; P interaction = 0.005) also were found in the DASH group compared with the control group. CONCLUSION: Consumption of DASH diet for 8 wk led to a significant reduction in serum insulin, triglycerides and very-low-density lipoprotein cholesterol and a significant increase in TAC and GSH levels.